89bio Inc   (ETNB)
Other Ticker:  


89bio Inc

ETNB's Financial Statements and Analysis

89bio Inc narrowed IV. Quarter net loss per share of $-0.31 compare to net loss per share of $-2.63 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.57 realized in previous quarter.

IV. Quarter
Earnings Per Share Revenues
$ -0.31 $  0 Mill
$+2.32     Unch.    

89bio Inc 's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.

89bio Inc is Expected to report next financial results on May 11, 2023.

More on ETNB's Income Statement

89bio Inc 's in IV. Quarter recorded net loss of $-24.602 million, an improvement compare to net loss of $-61.614 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-26.805 million realized in previous quarter.

More on ETNB's Growth

89bio Inc Inventories
In IV. Quarter company's net cash and cash equivalents decreased by $-17 million, capital expenditures grew by -92.59%, to $0 millions compare to same quarter a year ago and fell by